Keynote: A big pharma research platform, for all our partners
Wolf-Dieter Busse, SVP, Head of Biotechnology R&D, Bayer Corporation Keynote:
A big Pharma research platform, for all our partners
More Articles
Keynote: 21st Century procurement the GlaxoSmithKline way
Keynote: 21st Century procurement the GlaxoSmithKline way Willie Deese, SVP
Global Procurement, GlaxoSmithKline
Commercial
Executive Case Study: Proteomics - the next quest in the post genomics era
BUSINESS IN THE POST GENOMICS ERA: CHAIRED BY: Dr Romeo Paioni, Head
Scientific and External Affairs, Novartis Pharma
4SC and PACT complete virtual HTP drug screening pilot
Through a combination of 4SC's proprietary virtual-high-throughput technology
and PACT's XPU microprocessor technology, the alliance contends it has been
able to increase the speed of computer
Agilent and Merck to continue gene expression analysis solutions alliance
On May 11, Merck and Rosetta announced an agreement under which Merck will
acquire Rosetta.
Commercial
Wyeth Lederle signs Adera to develop Internet and IT initiatives
Adera will be responsible for the management and quality control of Wyeth
Lederle's Web site and will also be involved in the strategic work to develop
Wyeth Lederle's future Internet and IT i
Commercial
Aventis pilots new initiative for physician interaction
Using a PC and browser, physicians go to a secure Web site, log-on, and
connect with a medical information specialist. Once connected, the
MGI PHARMA chooses EventNet for adverse events reporting
EventNet is used to actively manage, analyze and report adverse events,
product complaints and medical communication requests.
Cellular Genomics announces agreement with InforMax
GenoMax is a modular family of tools, each designed to work with one or more
types of genomic and proteomic data, including sequence information, gene
expression data, and protein structure.